Utility of thin-layer preparations in endometrial cytology: Immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions
Authors:
- Tomoyuki MiyamotoTMTomoyuki Miyamoto
- Tadao K. KobayashiTKTadao K. Kobayashi
- Tomohiro OdaTOTomohiro Oda
- Takuya MoriyaTMTakuya Moriya
- Kenji YanohKYKenji Yanoh
- Yasuyuki MiyakeYMYasuyuki Miyake
- Eiji OhnoEOEiji Ohno
- 11 March 2008
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 36 (4) , 216-223
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Molecular and Pathologic Aspects of Endometrial CarcinogenesisJournal of Clinical Oncology, 2006
- Endometrial glandular and stromal breakdown, part 2: Cytomorphology of papillary metaplastic changesDiagnostic Cytopathology, 2006
- Involution of PTEN-null endometrial glands with progestin therapyGynecologic Oncology, 2004
- PTEN Mutational Spectra, Expression Levels, and Subcellular Localization in Microsatellite Stable and Unstable Colorectal CancersThe American Journal of Pathology, 2002
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Increased Detection of Epithelial Cell Abnormalities by Liquid-Based Gynecologic Cytology PreparationsActa Cytologica, 1998
- p53 Overexpression and bcl-2 Persistence in Endometrial Carcinoma: Comparison of Papillary Serous and Endometrioid SubtypesGynecologic Oncology, 1996
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994
- p53, guardian of the genomeNature, 1992
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983